CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS OF RESECTED HEPATOCELLULARCARCINOMAS OF VARIED SIZES WITH SPECIAL REFERENCE TO PROLIFERATING CELL NUCLEAR ANTIGEN
T. Suehiro et al., CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS OF RESECTED HEPATOCELLULARCARCINOMAS OF VARIED SIZES WITH SPECIAL REFERENCE TO PROLIFERATING CELL NUCLEAR ANTIGEN, Cancer, 76(3), 1995, pp. 399-405
Background. Proliferating cell nuclear antigen (PCNA) is an intranucle
ar protein that is linked closely to the cell cycle. An immunohistoche
mical study was performed on the expression of PCNA in various sized h
epatocellular carcinomas (HCCs) to determine the relation between the
proliferative activity of cancer cells and prognosis. Methods. One hun
dred forty-one neoplasms resected from 141 patients who underwent hepa
tic surgery for HCC at Kyushu University hospital from April, 1991, to
July, 1993, were studied immunohistochemically using monoclonal antib
ody for PCNA (PC10), and analyzed for a possible correlation between P
CNA labeling index (PCNA-LI) and the prognosis of patients with HCC. R
esults. Proliferating cell nuclear antigen reactive cancer cells were
observed throughout the HCC. The PCNA-LI ranged from 1.2%-91.6%, with
a mean of 37.7%. The high PCNA-LI (>37.7) group showed a significantly
higher incidence of tumor thrombus in the portal vein, higher Edmonds
on's Grade, and a higher recurrence rate than the low PCNA-LI (<37.7)
group. Hepatocellular Carcinomas were divided into three groups accord
ing to tumor size. Based on the clinicopathologic findings, in small (
<30 mm) HCCs, the high PCNA-LI (>29.0) group showed a significant high
er Edmondson's grade and a higher recurrence rate than the low PCNA-LI
(<29.0) group. In medium (30-60 mm) HCCs, the high PCNA-LI (>36.1) gr
oup showed a significantly higher recurrence rate than the low PCNA-LI
(<36.1) group, although there was no difference in the pathologic fin
dings between the high (>59.4) and low (<59.4) PCNA-LI groups. Conclus
ions. Proliferating cell nuclear antigen labeling index is closely rel
ated to cell differentiation and the prognosis of HCC. Furthermore, PC
NA-LI was found to be useful in predicting the intrahepatic spread and
prognosis of small (<30 mm) and medium (30-60 mm) but not large (>60
mm) HCCs.